Australia, Jan. 4 -- Clinuvel Pharmaceuticals Ltd. (CUV) has reported gross short sales of 16,538 FPO shares on Jan. 2. The percent of issued capital of the company reported as short sales is 0.03 percent. The issued capital of the company is 50,060,680 shares.
Disclaimer: Curated by HT Syndication.
